Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 11/03/2020 17:58:03 | FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2019 BOOK CLOSURE TO 21/05/2020 BOOK CLOSURE FROM 15/05/2020 ANNUAL GENERAL MEETING WILL BE HELD ON 21/05/2020 EPS = 9.55 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 3,041.123 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,600.296 DIVIDEND = 60%(F) |
| 28/10/2019 14:55:13 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2019 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,860.721 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,798.349 EPS = 5.65 |
| 28/08/2019 15:10:02 | FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2019 EPS = 2.75 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 874.588 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,586.813 |
| 24/04/2019 14:43:25 | FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2019 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 817.623 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 532.910 EPS = 1.67 |
| 04/03/2019 16:53:04 | BOOK CLOSURE FROM 18/04/2019 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2018 DIVIDEND = 70%(F) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,692.117 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 3,231.922 EPS = 10.23 ANNUAL GENERAL MEETING WILL BE HELD ON 24/04/2019 BOOK CLOSURE TO 24/04/2019 |